http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4786636-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5deddb47ccaab1d4da2aacc344dd8717 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 1987-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1988-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c52c76da2649a0e1b84da579505ca3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e8a9547e5902e2cf0583d890205ceb |
| publicationDate | 1988-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4786636-A |
| titleOfInvention | Thiazino-benzimidazoles and their use as antiulcer agents |
| abstract | This invention relates to a method of treating ulcers or hypersecretion in a mammal which comprises administering a compound of formula <IMAGE> (I) or a pharmaceutically acceptable salt thereof wherein -B-B1- represents a chain of formula -CR5=CR6-(Ib) or -(CHR5)n-CR6=(Ic); R represents an optionally substituted aryl or heteroaryl radical; R1, R2, R3 and R4 independently represent hydrogen, or a defined substituent or any adjacent pair of R1, R2, R3 and R4 together with the carbon atoms to which they are attached complete a five or six membered saturated or unsaturated carbocyclic or heterocyclic ring, said ring being optionally substituted by a defined substituent said heterocyclic ring having at least one heteroatom selected from oxygen, nitrogen and sulphur. Novel compositions and compounds of formula I are also disclosed. |
| priorityDate | 1983-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 222.